Engineered immune cells battle acute leukaemia

@article{Ledford2013EngineeredIC,
  title={Engineered immune cells battle acute leukaemia},
  author={Heidi Ledford},
  journal={Nature},
  year={2013}
}
Modified T cells seek out and destroy blood cancer. 

Topics from this paper

References

CD19-Targeted T Cells Rapidly Induce Molecular Remissions in Adults with Chemotherapy-Refractory Acute Lymphoblastic Leukemia
TLDR
The results demonstrate the marked antitumor efficacy of 19-28z CAR-modified T cells in patients with relapsed/refractory B-ALL and the reliability of this therapy to induce profound molecular remissions, forming a highly effective bridge to potentially curative therapy with subsequent allo-HSCT. Expand